K. Wood

发表

Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency

J. Chmiel, K. Lichtenstein, C. Armon, 2008, Journal of acquired immune deficiency syndromes.

Provider Compliance With Guidelines for Management of Cardiovascular Risk in HIV-Infected Patients

J. Chmiel, K. Lichtenstein, C. Armon, 2013, Preventing chronic disease.

Ongoing Sexually Transmitted Disease Acquisition and Risk-Taking Behavior Among US HIV-Infected Patients in Primary Care: Implications for Prevention Interventions

A. Caliendo, J. Papp, K. Wood, 2012, Sexually transmitted diseases.

Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study

K. Lichtenstein, K. Buchacz, K. Wood, 2015, Journal of acquired immune deficiency syndromes.

Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort.

J. Chmiel, K. Buchacz, A. Moorman, 2006, Journal of acquired immune deficiency syndromes.

Seasonal influenza vaccination rates in the HIV outpatient study-United States, 1999-2013.

C. Armon, K. Buchacz, K. Wood, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low Bone Mineral Density and Risk of Incident Fracture in HIV-Infected Adults

Linda A. Battalora, J. Chmiel, C. Armon, 2016, Antiviral therapy.

Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.

K. Buchacz, A. Moorman, K. Wood, 2009, AIDS patient care and STDs.

Immune reconstitution inflammatory syndrome: incidence and implications for mortality

J. Chmiel, K. Buchacz, K. Wood, 2012, AIDS.

AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study

J. Chmiel, K. Lichtenstein, K. Buchacz, 2010, AIDS.

Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study

John T Brooks, J. Chmiel, A. Moorman, 2006, Journal of acquired immune deficiency syndromes.

Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons.

C. Armon, A. Moorman, K. Wood, 2006, AIDS patient care and STDs.

Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.

A. Moorman, K. Wood, S. Holmberg, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.

A. Moorman, K. Wood, S. Holmberg, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

P. Rhodes, D. Ward, K. Lichtenstein, 2001, AIDS.

The Association of HIV Susceptibility Testing With Survival Among HIV-Infected Patients Receiving Antiretroviral Therapy: A Cohort Study

S. Cole, J. Chmiel, C. Armon, 2009, Annals of Internal Medicine.

Increased Body Mass Index Does Not Alter Response to Initial Highly Active Antiretroviral Therapy in HIV-1-Infected Patients

K. Buchacz, A. Moorman, K. Wood, 2006, Journal of acquired immune deficiency syndromes.

Renal Function in Tenofovir-Exposed and Tenofovir-Unexposed Patients Receiving Highly Active Antiretroviral Therapy in the HIV Outpatient Study

J. Chmiel, K. Buchacz, A. Moorman, 2007, Journal of the International Association of Physicians in AIDS Care.

Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata

Maria Deloria-Knoll, Alan Greenberg, Scott Holmberg, 2003, Annals of Internal Medicine.

Factors Associated With Cancer Incidence and With All-Cause Mortality After Cancer Diagnosis Among Human Immunodeficiency Virus-Infected Persons During the Combination Antiretroviral Therapy Era

J. Chmiel, C. Armon, K. Buchacz, 2014, Open forum infectious diseases.

Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care – Washington, DC*

H. Masur, K. Wood, M. Ruiz, 2016, AIDS care.

Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions

Rachel Hart, Kathy Wood, Alan E. Greenberg, 2016, J. Am. Medical Informatics Assoc..

Initiation of HAART at Higher CD4 Cell Counts Is Associated With a Lower Frequency of Antiretroviral Drug Resistance Mutations at Virologic Failure

C. Armon, K. Buchacz, K. Wood, 2009, Journal of acquired immune deficiency syndromes.

The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).

K. Wood, S. Holmberg, J. Brooks, 2008, American journal of epidemiology.

Factors associated with non-adherence to antiretroviral therapy in the SUN study

K. Buchacz, K. Wood, J. Brooks, 2011, AIDS care.

Factors associated with maintenance of long-term plasma human immunodeficiency virus RNA suppression.

A. Moorman, K. Wood, S. Holmberg, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005

K. Buchacz, A. Moorman, K. Wood, 2008, AIDS.

HIV Laboratory Monitoring Reliably Identifies Persons Engaged in Care

K. Buchacz, K. Wood, J. Brooks, 2015, Journal of acquired immune deficiency syndromes.

Antiretroviral nonadherence and condomless sex in the HIV Outpatient Study, USA, 2007–2014

K. Buchacz, K. Wood, M. Durham, 2018, International journal of STD & AIDS.

CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality risk.

J. Chmiel, K. Lichtenstein, C. Armon, 2016, The Journal of antimicrobial chemotherapy.

A Matter of Perspective: Comparison of the Characteristics of Persons with HIV Infection in the United States from the HIV Outpatient Study, Medical Monitoring Project, and National HIV Surveillance System

J. Skarbinski, J. Chmiel, C. Armon, 2015, The open AIDS journal.

Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States.

J. Palefsky, K. Wood, J. Brooks, 2010, The Journal of infectious diseases.

Sexual Risk Behavior and Viremia Among Men Who Have Sex With Men in the HIV Outpatient Study, United States, 2007–2010

K. Buchacz, K. Wood, J. Brooks, 2013, Journal of acquired immune deficiency syndromes.

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

John M Williamson, R. Janssen, D. Ward, 2002, The Lancet.

Incidence of and Risk Factors for Lipoatrophy (Abnormal Fat Loss) in Ambulatory HIV-1-Infected Patients

D. Ward, K. Lichtenstein, C. Armon, 2003, Journal of acquired immune deficiency syndromes.

A 7-year longitudinal analysis of IL-2 in patients treated with highly active antiretroviral therapy.

K. Lichtenstein, C. Armon, A. Moorman, 2004, AIDS.

Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.

J. Chmiel, K. Lichtenstein, C. Armon, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.

K. Lichtenstein, K. Wood, J. Brooks, 2016, AIDS research and human retroviruses.

New Fracture Risk And Frax 10-Year Probability Of Fracture In Hiv-Infected Adults

Linda A. Battalora, J. Chmiel, C. Armon, 2014 .

Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.

K. Lichtenstein, C. Armon, A. Moorman, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Polypharmacy and Risk of Antiretroviral Drug Interactions Among the Aging HIV-Infected Population

J. Chmiel, C. Armon, K. Buchacz, 2013, Journal of General Internal Medicine.

Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States.

K. Buchacz, K. Wood, J. Brooks, 2012, AIDS patient care and STDs.

Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999-2008.

C. Armon, K. Buchacz, K. Wood, 2011, Preventive medicine.

Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantification

D. Ward, A. Moorman, K. Wood, 2002, AIDS.

J. Chmiel, A. Moorman, K. Wood, 2004, AIDS patient care and STDs.

Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral Therapy.

J. Palefsky, K. Wood, J. Brooks, 2016, The Journal of infectious diseases.

Long-term immunologic and virologic responses on raltegravir-containing regimens among ART-experienced participants in the HIV Outpatient Study

J. Chmiel, C. Armon, K. Buchacz, 2015, HIV clinical trials.

Factors Associated With Initiation of Prolonged Analgesic Use Among Patients in the HIV Outpatient Study (HOPS)

J. Chmiel, K. Lichtenstein, C. Armon, 2011, The Clinical journal of pain.